This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Manni, A. Articles by Feil, P. Search for Related Content PubMed PubMed Citation Articles by Manni, A. Articles by Feil, P.

Promotion by Prolactin of the Growth of Human Breast Neoplasms Cultured in Vitro in the Soft Agar Clonogenic Assay¹

Division of Endocrinology, Departments of Medicine and Surgery, The Milton S. Hershey Medical Center, The Pennsylvania State University, Hershey, Pennsylvania 17033

The role of prolactin (PRL) in supporting the growth of human breast cancer is still unclear. The ability to grow primary breast cancer specimens in the soft agar clonogenic assay in the absence of serum gave us the opportunity to evaluate the growth-promoting effect of PRL and to compare it to that of estradiol in the same tumor samples. PRL was tested both at physiological concentrations (20 ng/ml) as well as in pharmacological amounts (200 ng/ml) comparable to circulating blood levels in hyperprolactinemic states. Estradiol was simultaneously tested in physiological amounts (10^-8 M). In 17 infiltrating ductal carcinomas, the lower dose of PRL stimulated colony formation to 126 ± 5.2% (SE) of control, while the higher dose increased colony number to 159 ± 10.4% of control. This latter effect was comparable to that observed with estradiol (159 ± 8.5% of control). The effect of PRL was more pronounced in estrogen receptor-positive tumors. Nine of ten estrogen receptor-positive tumors were PRL sensitive, while three of seven estrogen receptor-negative tumors exhibited a clear response to PRL administration. PRL did not stimulate colony formation in a malignant cystosarcoma phylloides and in two benign lesions (fibroadenoma and fibrocystic disease). We conclude that, at least under the conditions of the soft agar clonogenic assay, PRL exerts a dose-dependent growth-promoting effect on human breast cancer. Such effect is comparable to that of estradiol when PRL is added in concentrations similar to circulating blood levels in hyperprolactinemic patients.

¹ This work was supported in part by National Cancer Institute Grant CA35944.

² Present address: Department of Surgery, Northwestern University, The Medical School, 250 E. Superior St., Suite 201, Chicago, IL 60611.

Received 9/17/85. Revised 12/ 3/85. Accepted 12/30/85.